R. J. Glassock, The pathogenesis of idiopathic membranous nephropathy: a 50-year odyssey, Am J Kidney Dis, vol.56, pp.157-167, 2010.

L. H. Beck, R. G. Bonegio, G. Lambeau, D. M. Beck, D. W. Powell et al., M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy, N Engl J Med, pp.11-21, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00417718

Y. Du, J. Li, F. He, Y. Lv, W. Liu et al., The diagnosis accuracy of PLA2R-AB in the diagnosis of idiopathic membranous nephropathy: a meta-analysis, PLoS One, vol.9, p.104936, 2014.

P. Ronco and H. Debiec, Pathophysiological advances in membranous nephropathy: time for a shift in patient's care, Lancet, vol.385, 1983.

L. Kao, V. Lam, M. Waldman, R. J. Glassock, and Q. Zhu, Identification of the immunodominant epitope region in phospholipase A2 receptormediating autoantibody binding in idiopathic membranous nephropathy, J Am Soc Nephrol, vol.26, pp.291-301, 2015.

M. Fresquet, T. A. Jowitt, J. Gummadova, R. Collins, R. O'cualain et al., Identification of a major epitope recognized by PLA2R autoantibodies in primary membranous nephropathy, J Am Soc Nephrol, vol.26, pp.302-313, 2015.

P. Shah, A. Tramontano, and S. P. Makker, Intramolecular epitope spreading in Heymann nephritis, J Am Soc Nephrol, vol.18, pp.3060-3066, 2007.

P. Ronco and H. Debiec, Pathophysiological lessons from rare associations of immunological disorders, Pediatr Nephrol, vol.24, pp.3-8, 2009.

E. Hintermann, M. Holdener, M. Bayer, S. Loges, J. M. Pfeilschifter et al., Epitope spreading of the anti-CYP2D6 antibody response in patients with autoimmune hepatitis and in the CYP2D6 mouse model, J Autoimmun, vol.37, pp.242-253, 2011.

B. Seitz-polski, G. Dolla, C. Payre, C. A. Girard, J. Polidori et al., Epitope spreading in PLA2R1 is associated with bad prognosis in membranous nephropathy, J Am Soc Nephrol, vol.27, pp.1517-1533, 2016.

W. G. Laver, G. M. Air, R. G. Webster, and S. Sj, Gozalbo-Rovira R, Rodríguez-Díaz J, Saus J, Cervera J: Precise mapping of the Goodpasture epitope(s) using phage display, site-directed mutagenesis, and surface plasmon resonance, Epitopes on protein antigens: misconceptions and realities, vol.61, pp.438-445, 1990.

S. D. Miller, D. M. Turley, and J. R. Podojil, Antigen-specific tolerance strategies for the prevention and treatment of autoimmune disease, Nat Rev Immunol, vol.7, pp.665-677, 2007.

J. Reynolds, D. S. Abbott, J. Karegli, D. J. Evans, and C. D. Pusey, Mucosal tolerance induced by an immunodominant peptide from rat alpha3(IV)NC1 in established experimental autoimmune glomerulonephritis, Am J Pathol, vol.174, pp.2202-2210, 2009.

P. Y. Gan, D. S. Tan, J. D. Ooi, M. A. Alikhan, A. R. Kitching et al., Myeloperoxidase peptide-based nasal tolerance in experimental ANCA-associated GN, 2015.

, J Am Soc Nephrol

H. C. Stanescu, M. Arcos-burgos, A. Medlar, D. Bockenhauer, A. Kottgen et al., Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy, N Engl J Med, vol.364, pp.616-626, 2011.

A. Tramontano, T. Knight, D. Vizzuso, and S. P. Makker, Nested N-terminal megalin fragments induce high-titer autoantibody and attenuated Heymann nephritis, J Am Soc Nephrol, vol.17, 1979.

J. Radhakrishnan and D. C. Cattran, The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines-application to the individual patient, Kidney Int, vol.82, pp.840-856, 2012.

Y. Pan, J. Wan, Y. Liu, Q. Yang, W. Liang et al., sPLA2 IB induces human podocyte apoptosis via the M-type phospholipase A2 receptor. Sci Rep, vol.4, 2014.

A. Augert, C. Payré, Y. De-launoit, J. Gil, G. Lambeau et al., The M-type receptor PLA2R regulates senescence through the p53 pathway, EMBO Rep, vol.10, pp.271-277, 2009.
URL : https://hal.archives-ouvertes.fr/hal-00417702

O. Llorca, Extended and bent conformations of the mannose receptor family, Cell Mol Life Sci, vol.65, pp.1302-1310, 2008.